Innovating Works

ACRO

Desconocido
EURE-CART: EURopean Endeavour for Chimeric Antigen Receptor Therapies ACROMION GMBH participó en un H2020: H2020-SC1-2016-2017 Cancer is rapidly becoming the most frequent cause of death in EU. Though enormously expensive (several billions EUR/year), currently availa...
2016-12-05 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.